Use of a long acting glp-1 / glucagon receptor dual agonist for the treatment of non-alcoholic fatty liver disease

MA40466AUndetermined Publication Date: 2016-03-24HANMI PHARM CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA40466
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-09-16
Filing Date: 2015-09-16
Publication Date: 2016-03-24

Application Information

Patent Timeline

16 Sep 2014

Priority

16 Sep 2015

Application

MA40466

24 Mar 2016

Publication

MA40466A

IPC: A61K38/26; A61P1/16

CPC: A61K38/26; A61K49/0008; A61K47/60; A61K47/6811; A61P1/16; A61P35/00; A61P3/06; C07K16/00

Inventors: CHOI In Young; HWANG Sang Youn

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease including a long-acting glp-1 / glucagon receptor dual agonist, and a method for preventing or treatment of non-alcoholic fat

Need to check novelty before this filing date? Find Prior Art